Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/89
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBarno Kh. Shagazatova 1, Said K. Bakhadirov 2, Bakhtiyor R. Mamasodikov 3-
dc.date.accessioned2024-11-20T10:08:00Z-
dc.date.available2024-11-20T10:08:00Z-
dc.date.issued2024-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/89-
dc.description.abstractOne of the most studied genetic factors in the context of DN is the methylenetetrahydrofolate reductase (MTHFR) gene, specifically the C677T polymorphism. This single nucleotide polymorphism (SNP) is associated with elevated plasma homocysteine levels, which are known to contribute to vascular damage and the progression of nephropathy in diabetic patients. Research consistently shows that the 677T allele, particularly in individuals with the homozygous form (TT genotype), significantly increases the risk of developing DN across various populations.en_US
dc.language.isoen_USen_US
dc.publisherCentral Asian Journal of Medicineen_US
dc.subjectmitral valve genetic polymorphisms, diabetic nephropathy, markers.en_US
dc.titleCOMPARATIVE ANALYSIS OF FOLATE CYCLE MARKERS IN PATIENTS WITH TYPE 2 DIABETES COMPLICATED BY DIABETIC NEPHROPATHYen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
836-Article Text-1956-1-10-20240928.pdfCOMPARATIVE ANALYSIS OF FOLATE CYCLE MARKERS IN PATIENTS WITH TYPE 2 DIABETES COMPLICATED BY DIABETIC NEPHROPATHY131.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.